Congressional Testimony 2007

-

November

11/14/2007 Dental Amalgams and the National Environmental Policy Act of 1969
Norris Alderson, Ph.D., before the House Committee on Oversight and Government Reform, Subcommittee on Domestic Policy
11/13/2007 Food Protection Plan and Import Safety Action Plan
David Acheson, M.D., F.R.C.P., before the Senate Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
11/01/2007 FDA's Foreign Drug Inspection Program
Andrew C. von Eschenbach, M.D., before the Senate Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

-

10/11/2007 Safety of FDA-regulated Products
David W. K. Acheson, M.D., before the Senate Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
10/04/2007 Import Safety
Steven M. Solomon, D.V.M., M.P.H., before the House Committee on Ways and Means, Subcommittee on Trade
10/03/2007 H.R. 1108, Family Smoking Prevention and Tobacco Control Act
Andrew C. von Eschenbach, M.D., before the Senate Committee on Energy and Commerce, Subcommittee on Health

-

09/26/2007 Safety of Imported FDA-regulated Products
Randall Lutter, Ph.D., before the Senate Committee on Energy and Commerce, Subcommittee on Health
09/25/2007 Food Safety and Food Imports from China
David Acheson, M.D., F.R.C.P., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies

-

07/24/2007 Food Safety Activities
David Acheson, M.D., F.R.C.P., before the Senate Committee on Homeland Security, Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology
07/18/2007 Safety of Chinese Imports
Murray M. Lumpkin, M.D., before the Senate Committee on Commerce, Science, and Transportation
07/17/2007 Alzheimer's Disease: FDA's Role In New Product Development
Andrew C. von Eschenbach, M.D., before the Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Retirement and Aging

-

06/26/2007 Erythropoiesis-Stimulating Agents (ESA)
John K. Jenkins, M.D., before the House Committee on Ways and Means, Subcommittee on Health
06/12/2007 Hearing on PDUFA, MDUFMA, Drug Safety, and Pediatric Device Legislation
Randall Lutter, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
06/06/2007 Safety of Rosiglitazone Maleate (Avandia)
Andrew C. von Eschenbach, M.D., before the House Committee on Oversight and Government Reform
06/01/2007 Critical Path Initiative
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration and Related Agencies

-

05/22/2007 Programs Affecting Safety and Innovation in Pediatric Therapies
Rear Admiral Sandra Lynn Kweder, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
05/16/2007 Implementing MDUFMA
Jeffrey E. Shuren, M.D., J.D., before the House Committee on Energy and Commerce, Subcommittee on Health
05/15/2007 Fresh Produce and Foodborne Illness Outbreaks
David Acheson, M.D., F.R.C.P., before the House Committee on Agriculture, Subcommittee on Horticulture and Organic Agriculture
05/09/2007 Strengthening the Science of Drug Safety
Steven Galson, M.D., M.P.H., before the House Committee on Energy and Commerce, Subcommittee on Health
05/09/2007 Importation of Contaminated Animal Feed Ingredients
David Acheson, M.D., F.R.C.P., before the House Committee on Agriculture
05/02/2007 Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
05/01/2007 Overview of FDA Mission
Andrew C. von Eschenbach, M.D., before the House Committee on Oversight and Government Reform

-

04/25/2007 FDA's Role in Measuring and Assessing Perchlorate Levels in Food and Beverages
Robert E. Brackett, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Environment and Hazardous Materials
04/19/2007 Pharmacy Compounding/Compounding of Bio-identical Hormone Replacement Therapies
Steven K. Galson, M.D., M.P.H., before the Senate Special Committee on Aging
04/18/2007 FDA's Role in Regulating Vaccines
Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Homeland Security (Appropriations), Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology
04/17/2007 Prescription Drug User Fee Act (PDUFA)
Theresa M. Mullin, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
04/12/2007 Contamination of Pet Food
Stephen F. Sundlof, D.V.M., Ph.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

-

03/26/2007 Follow-on Protein Products
Janet Woodcock, M.D., before the House Committee on Oversight and Government Reform
03/22/2007 The Future of FDA's Drug Safety Program
Andrew C. von Eschenbach, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
03/14/2007 FDA's Success in Implementing PDUFA
Andrew C. von Eschenbach, M.D., before the Senate Committee on Health, Education, Labor and Pensions
03/12/2007 FDA's Planned Improvements for Food Safety
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
03/07/2007 Policy Implications of Importing Drugs in the United States
Randall W. Lutter, Ph.D., before the Senate Committee on Commerce, Science, and Transportation, Subcommittee on Interstate Commerce, Trade, and Tourism

-

02/27/2007 Fiscal Year 2008 FDA Budget Request
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

-